Bao et al. found that irradiation enriched the subpopulation of cells expressing CD133+, a marker for brain cancer stem cells, in glioblastoma tumor specimens as well as xenografts and cell cultures derived from glioma xenografts. This evidence concerns the gene PROM1 and glioma.